Human papillomavirus 11-valent recombinant vaccine (National Vaccine and Serum Institute)

A total of 13500 Chinese women aged 18-45 years old were divided into three age groups: 18-26 years old, 27-35 years old, and 35-45 years old. The experimental group and the placebo group were randomly assigned in a ratio of 1:1. All subjects enrolled in the upper arm deltoid muscle were injected with 3 doses of test vaccine or placebo according to the 0, 2, and 6 months immunization program.

免疫原性：评价18-26岁中国女性接种3剂试验疫苗后30天的免疫原性，并与阳性对照疫苗进行比较。 安全性：评价18-26岁中国女性接种11价重组HPV疫苗（汉逊酵母）的安全性。